As the scientific community weighs the risks and rewards of CRISPR, a controversial gene-editing tool, scientists in New York City are moving forward with experiments changing DNA on human sperm. In response to these new germline (heritable) experiments and the broader conversation surrounding CRISPR, Charlotte Lozier Institute (CLI), the research and education arm of Susan B. […]
The following are selected articles authored or co-authored by Charlotte Lozier Institute staff on issues involving gene editing.
On December 28, 2016, CLI’s Vice President and Research Director, Dr. David Prentice, co-authored an op-ed with Congressman Dr. Michael Burgess (R-Tex.) on the ethical and unethical uses of human gene editing, especially in light of the advent of the CRISPR-Cas System.